Sales soared 36 per cent for Croda International, with strong growth reported alongside the £145 million generated from coronavirus vaccine-related ingredients.
Annual results for the East Yorkshire smart science giant published to the City showed a turnover of £1.9 billion in 2021, up from £1.4 billion.
Without the huge input into the Pfizer jabs, sales were still up 18 per cent on 2019, with half year results having given a strong indication back in August.